Blue Surgical Llc
$12.0K 158 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
Pfizer S.a.
Pfizer S.a. reported $11,940.00 across General Payments, Research, and Ownership to 3 physicians and teaching hospitals across 3 transactions.
- $11.9K Below-median payer
- All-tracks total
- 3 Below-median volume
- Transactions
- 3 Below-median reach
- Recipients
- #1617
- of 1,925 companies
Pfizer S.a. reported $11,940.00 across all CMS Open Payments tracks (General + Research + Ownership) to 3 physicians and teaching hospitals in Program Year 2024 - ranking #1617 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $11,940.00, averaging $4.0K per recipient.
Pfizer S.a.'s payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
10/100
Total payments
F
10/100
Transaction volume
F
10/100
Physician reach
F
10/100
Payment type diversity
F
10/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer pfizer-s-a Pfizer S.a.
$11.9K · #1617/1,925 · 0.0% industry · PY2024
- TOT $11.9K
- RANK #1617
- SHARE 0.0%
- TXN 3
- RCP 3
- CAT 1
- GEN $11.9K
- TOP1 60.6%
- PY 2024
Volume peers
Nearest volume peer: Blue Surgical Llc ($12.0K)
Pfizer S.a. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
What the Data Shows for Pfizer S.a.
Three separate CMS disclosure tracks feed the all-tracks total above - General, Research, and Ownership/Investment - each reported under its own rules and combined here for one comparable figure. For Pfizer S.a. that figure is drawn almost entirely from the General Payments track (day-to-day consulting, meals, travel and speaking fees). CMS releases each Program Year roughly 12 months after it ends; the methodology page covers the full standardization basis.
"Compensation for Services Other Than Consulting" leads the 1-category general-payment breakdown below at $11.9K (100.0% of General Payments, 3 transactions) - see our methodology for how research and ownership payments are reported separately.
General Payment Breakdown by Type
Pfizer S.a. made 1 types of general payments. "Compensation for Services Other Than Consulting" is the largest category at $11.9K, 100.0% of General Payments.
How Pfizer S.a. divides its payments
How the reported total splits across payment categories
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Compensation for Services Other Than Consulting | $11.9K | 3 | 100.0% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $11,940.00 (100.0%) of $11,940.00 in this company's General Payments records across 3 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Pfizer S.a.
The five named recipients with the highest reported General Payments from this company
- 1
Deborah Friedman
$7,240.00 across 1 reported transactions
- 2
Andrew Charles
$2,700.00 across 1 reported transactions
- 3
Richard Lipton
$2,000.00 across 1 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Pfizer S.a. ranks #1617 of 1,925 by total payments (bottom 16% by spend) but is notably more concentrated than that alone would suggest -- #416 of 1,838 by HHI (top 23% most concentrated). Its payments land on an unusually narrow set of recipients for its spend size.
View all 12 companies in this HHI neighborhood as a list
- VentureMed Group, Inc. : $53.9K total payments, HHI 4505
- Silony Medical Corp. : $70.7K total payments, HHI 4493
- Pillar Biosciences, Inc : $3.3K total payments, HHI 4491
- AnX Robotica Corp : $31.6K total payments, HHI 4488
- American National Red Cross : $2.1K total payments, HHI 4487
- Elekta LTD : $857.01 total payments, HHI 4470
- Pfizer S.a. (this company) : $11.9K total payments, HHI 4469
- Noctrix Health, Inc. : $30.7K total payments, HHI 4446
- Spectra Medical Devices, LLC : $2.7K total payments, HHI 4434
- Meticuly Inc. : $1.6K total payments, HHI 4429
- Eton Pharmaceuticals, Inc. : $80.6K total payments, HHI 4392
- Circinus Medical Technology LLC : $5.3K total payments, HHI 4376
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Pfizer S.a.'s, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Pfizer S.a..
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Pfizer S.a..
Showing 6 of 1,924 companies with CMS-reported payment data.
Astellas Pharma Europe BV
$12.0K 2 recipients
Compare payment profiles
Music City Medical Technologies, LLC
$11.8K 162 recipients
Compare payment profiles
Dutch Ophthalmic Research Center (International) B.V.
$12.1K 29 recipients
Compare payment profiles
Amnio Technology, LLC
$11.7K 8 recipients
Compare payment profiles
Smaio USA Corporation
$12.2K 46 recipients
Compare payment profiles
Put this to use
Pfizer S.a. ranks #1617 of 1,925 by all-tracks total payments, led by "Compensation for Services Other Than Consulting".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Compensation for Services Other Than Consulting" spend across every manufacturer, not just Pfizer S.a.. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.